Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher M Booth

Showing results (211-220 of 349) with videos related to

Pageof 35
Sort By:
Cancer Treatment Reviews|May 25, 2019
PD-L1 expression and clinical outcomes in patients with advanced urothelial carcinoma treated with checkpoint inhibitors: A meta-analysisKetan Ghate, Eitan Amir, Markus Kuksis, et al.
Diseases of the Colon and Rectum|May 9, 2020
Salvage Abdominoperineal Resection for Anal Squamous Cell Carcinoma: Use, Risk Factors, and Outcomes in a Canadian PopulationSunil V Patel, Gary Ko, Michael J Raphael, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 22, 2009
Presentation of nonfinal results of randomized controlled trials at major oncology meetingsChristopher M Booth, Aurélie Le Maître, Keyue Ding, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 25, 2012
Adjuvant chemotherapy for non-small-cell lung cancer in the elderly: a population-based study in Ontario, CanadaSinead Cuffe, Christopher M Booth, Yingwei Peng, et al.
The Lancet. Oncology|December 8, 2016
Relevance of randomised controlled trials in oncologyIan F Tannock, Eitan Amir, Christopher M Booth, et al.
Urology|February 10, 2015
Radical cystectomy and adjuvant chemotherapy for bladder cancer in the elderly: a population-based studyMichael J Leveridge, D Robert Siemens, William J Mackillop, et al.
Cancer|July 6, 2017
Establishing achievable benchmarks for quality improvement in systemic therapy for early-stage breast cancerMelanie Powis, Rinku Sutradhar, Alejandro Gonzalez, et al.
JAMA Oncology|June 8, 2023
Changes to Primary End Points in Randomized Clinical Trials on Immune Checkpoint Inhibitors in Urothelial, Renal Cell, and Lung Cancers: A Systematic ReviewAnke Richters, Hilin Yildirim, Christopher M Booth, et al.
Cancer|November 8, 2012
Time to adjuvant chemotherapy and survival in non-small cell lung cancer: a population-based studyChristopher M Booth, Frances A Shepherd, Yingwei Peng, et al.
Ecancermedicalscience|September 1, 2020
Training of oncologists: results of a global surveyDivyanshi Jalan, Fidel Rubagumya, Wilma M Hopman, et al.
Pageof 35

Showing results (211-220 of 349) with videos related to

Sort By:
Pageof 35
Cancer Treatment Reviews|May 25, 2019
PD-L1 expression and clinical outcomes in patients with advanced urothelial carcinoma treated with checkpoint inhibitors: A meta-analysisKetan Ghate, Eitan Amir, Markus Kuksis, et al.
Diseases of the Colon and Rectum|May 9, 2020
Salvage Abdominoperineal Resection for Anal Squamous Cell Carcinoma: Use, Risk Factors, and Outcomes in a Canadian PopulationSunil V Patel, Gary Ko, Michael J Raphael, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 22, 2009
Presentation of nonfinal results of randomized controlled trials at major oncology meetingsChristopher M Booth, Aurélie Le Maître, Keyue Ding, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 25, 2012
Adjuvant chemotherapy for non-small-cell lung cancer in the elderly: a population-based study in Ontario, CanadaSinead Cuffe, Christopher M Booth, Yingwei Peng, et al.
The Lancet. Oncology|December 8, 2016
Relevance of randomised controlled trials in oncologyIan F Tannock, Eitan Amir, Christopher M Booth, et al.
Urology|February 10, 2015
Radical cystectomy and adjuvant chemotherapy for bladder cancer in the elderly: a population-based studyMichael J Leveridge, D Robert Siemens, William J Mackillop, et al.
Cancer|July 6, 2017
Establishing achievable benchmarks for quality improvement in systemic therapy for early-stage breast cancerMelanie Powis, Rinku Sutradhar, Alejandro Gonzalez, et al.
JAMA Oncology|June 8, 2023
Changes to Primary End Points in Randomized Clinical Trials on Immune Checkpoint Inhibitors in Urothelial, Renal Cell, and Lung Cancers: A Systematic ReviewAnke Richters, Hilin Yildirim, Christopher M Booth, et al.
Cancer|November 8, 2012
Time to adjuvant chemotherapy and survival in non-small cell lung cancer: a population-based studyChristopher M Booth, Frances A Shepherd, Yingwei Peng, et al.
Ecancermedicalscience|September 1, 2020
Training of oncologists: results of a global surveyDivyanshi Jalan, Fidel Rubagumya, Wilma M Hopman, et al.
Pageof 35